This roundup discusses recent findings from a study that examined rates of previous infection with COVID-19, how vitamin D affects outcomes in hospitalized patients, and a newly-tested antibody cocktail...
This roundup discusses recent findings from a study contradicting earlier evidence into the way that SARS-COV-2 enters and infects cells, whether the virus will become seasonal, and new data on a...
The SECURE-IBD Registry was designed to identify the impact of the pandemic on patients with inflammatory bowel disease. Speaker Erica J. Brenner, MD, provided an update on what the registry has revealed at...
This roundup discusses and update to the authorization from the FDA for the use of remdesivir in patients with COVID-19, the accuracy of saliva-based tests, and the first confirmed case of reinfection in...
In a regional update on the pandemic, Gil Melmed, MD, and Christina Ha, MD, from Cedars-Sinai Medical Center in Los Angeles reviewed the impact of COVID-19 on patients with inflammatory bowel disease and...
This roundup discusses the recent authorization from the FDA for the use of convalescent plasma in patients with COVID-19, the effects of ACEi/ARB use in patients with hypertension and COVID-19, and the...
This roundup details a study into the effectiveness of remdesivir in patients with moderate cases of COVID-19, and several studies examining various methods of transmission of the virus.
This roundup details a study into the development of T cell responses in various levels of disease severity, the potential of an existing drug to treat COVID-19, and updates from the CDC.
